Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$4.5 - $7.51 $68,760 - $114,752
-15,280 Reduced 13.77%
95,694 $633,000
Q2 2023

Aug 14, 2023

SELL
$9.23 - $11.23 $235,604 - $286,656
-25,526 Reduced 18.7%
110,974 $1.12 Million
Q4 2022

Feb 14, 2023

BUY
$6.5 - $11.5 $42,250 - $74,750
6,500 Added 5.0%
136,500 $1.57 Million
Q3 2022

Nov 14, 2022

BUY
$7.36 - $9.15 $956,800 - $1.19 Million
130,000 New
130,000 $1.11 Million

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $51.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Kamunting Street Capital Management, L.P. Portfolio

Follow Kamunting Street Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.